[go: up one dir, main page]

IL162919A0 - Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b - Google Patents

Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b

Info

Publication number
IL162919A0
IL162919A0 IL16291903A IL16291903A IL162919A0 IL 162919 A0 IL162919 A0 IL 162919A0 IL 16291903 A IL16291903 A IL 16291903A IL 16291903 A IL16291903 A IL 16291903A IL 162919 A0 IL162919 A0 IL 162919A0
Authority
IL
Israel
Prior art keywords
alpha
oxo
bedroxy
androst
difluoro
Prior art date
Application number
IL16291903A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL162919A0 publication Critical patent/IL162919A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16291903A 2002-02-04 2003-02-03 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b IL162919A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202563.3A GB0202563D0 (en) 2002-02-04 2002-02-04 Process
PCT/EP2003/001116 WO2003066654A1 (en) 2002-02-04 2003-02-03 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid

Publications (1)

Publication Number Publication Date
IL162919A0 true IL162919A0 (en) 2005-11-20

Family

ID=9930365

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16291903A IL162919A0 (en) 2002-02-04 2003-02-03 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b

Country Status (22)

Country Link
US (1) US20050080065A1 (zh)
EP (1) EP1472271A1 (zh)
JP (1) JP2005521680A (zh)
KR (1) KR20040088050A (zh)
CN (1) CN1628125A (zh)
AR (1) AR038389A1 (zh)
AU (1) AU2003206837B2 (zh)
BR (1) BR0307352A (zh)
CA (1) CA2473753A1 (zh)
CO (1) CO5611116A2 (zh)
GB (1) GB0202563D0 (zh)
IL (1) IL162919A0 (zh)
IS (1) IS7350A (zh)
MX (1) MXPA04007529A (zh)
MY (1) MY140446A (zh)
NO (1) NO20043665L (zh)
NZ (1) NZ534044A (zh)
PL (1) PL372217A1 (zh)
RU (1) RU2333217C2 (zh)
TW (1) TW200307689A (zh)
WO (1) WO2003066654A1 (zh)
ZA (1) ZA200405515B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153462A0 (en) * 2002-12-16 2003-07-06 Chemagis Ltd Thiocarboxylic acid organic salts and processes utilizing the same
PT103202B (pt) * 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
CN100560598C (zh) * 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 氟替卡松丙酸酯的合成方法
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
US9303060B1 (en) * 2014-10-03 2016-04-05 Amphaster Pharmaceuticals, Inc. Methods of preparing intermediate of fluticasone propionate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852505A (en) * 1955-10-31 1958-09-16 American Cyanamid Co Aminodeoxyglycosidopurines
US3288781A (en) * 1964-12-18 1966-11-29 Upjohn Co Process for deacylating anhydro-lyxofuranosyl with nitrogen base
US4500711A (en) * 1977-03-21 1985-02-19 Burroughs Wellcome Co. Synthesis of leucovorin
CA1201114A (en) * 1980-02-15 1986-02-25 Gordon H. Phillipps Androstane carbothioates
ATE241589T1 (de) * 1999-06-11 2003-06-15 Hoffmann La Roche Verfahren zur herstellung des neuraminidase- inhibitoren ro-64-0796

Also Published As

Publication number Publication date
WO2003066654A1 (en) 2003-08-14
NO20043665L (no) 2004-09-01
RU2333217C2 (ru) 2008-09-10
CA2473753A1 (en) 2003-08-14
KR20040088050A (ko) 2004-10-15
AU2003206837A1 (en) 2003-09-02
AR038389A1 (es) 2005-01-12
MY140446A (en) 2009-12-31
MXPA04007529A (es) 2004-11-10
AU2003206837B2 (en) 2008-11-13
US20050080065A1 (en) 2005-04-14
RU2004121675A (ru) 2005-05-27
CN1628125A (zh) 2005-06-15
NZ534044A (en) 2006-10-27
CO5611116A2 (es) 2006-02-28
BR0307352A (pt) 2004-12-14
GB0202563D0 (en) 2002-03-20
TW200307689A (en) 2003-12-16
ZA200405515B (en) 2005-07-12
EP1472271A1 (en) 2004-11-03
JP2005521680A (ja) 2005-07-21
PL372217A1 (en) 2005-07-11
IS7350A (is) 2004-07-09

Similar Documents

Publication Publication Date Title
PL369740A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
ZA200307450B (en) Process for the production of synthesis gas.
AU2003281045A1 (en) Water-dispersible cellulose and process for producing the same
AU2003219592A1 (en) Chiral intermediate and process for the production thereof
MXPA03008041A (es) Proceso para la fabricacion de articulos moldeados.
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2003265589A8 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
AU2003245040A1 (en) Process for purifying pentafluoroethane, process for producing the same, and use thereof
AU2003242388A1 (en) Prodrug and process for producing the same
AU2003275675A1 (en) Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
ZA200500526B (en) Prodrug, medicinal utilization thereof and process for producing the same
EP1561434A4 (en) BITE ATTACHMENT, BIT AND MANUFACTURING PROCESS THEREFOR
EG23204A (en) Process for the production of quinazolines.
IL162919A0 (en) Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2003245663A1 (en) Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
EG23417A (en) Process for the preparation 7 a-methylsteroids.
AU2003201857A1 (en) Bisphosphine, process for producing the same, and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
EP1553073A4 (en) PROCESS FOR PREPARING 1,2,4-BUTANTRIOL
AU2003266528A1 (en) Cyclic amine compound, process for producing the same, and use